- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00850876
Heated Humidified Continuous Positive Airway Pressure and Nasal Physiology
Randomized Cross-over Trials of the Effect of Heated Humidified CPAP Versus Non-humidified CPAP on Nasal Physiology
Studieoversikt
Status
Detaljert beskrivelse
Introduction-Rationale:
Nasal continuous positive airway pressure (CPAP) is considered to be the "gold standard" of obstructive sleep apnoea (OSA) treatment [1]. The most common side effects are nasal congestion, stuffiness or dryness and rhinorrhea which have been reported in up to 68% of patients responding to a questionnaire about nasal CPAP. In many of them, CPAP compliance is accordingly compromised.
The mechanisms by which CPAP provokes nasal symptoms have been thoroughly studied only in healthy volunteers and a rodent model. Indeed, Richards et al demonstrated that mouth leaks causing high unidirectional nasal airflow increased nasal airway resistance and this response could be largely prevented by heated humidification of the inspired air. Similarly, Togias et al showed an elevated release of inflammatory mediators (histamine, prostaglandin D2, kinins) in nasal wash fluids when compressed cold and dry air was delivered through the nose. This effect was also prevented when warm and moist air was delivered. More recently, Almendros et al provided evidence that CPAP use in rats triggered early nasal inflammation.
Of the variety of methods used to treat nasal symptoms during CPAP treatment, the most common is humidification of the inspired air. However, the mechanism Oby which humidified CPAP attenuates nasal symptoms has never been assessed objectively in OSA patients. Therefore, the purpose of this study is to examine the effect of humidified CPAP on nasal airway physiology with combined measurements of nasal resistance and level of inflammatory markers. Our hypothesis is that the addition of heated humidification in CPAP decreases nasal airway resistance and nasal mucosal inflammation markers and thus, ameliorates nasal symptoms of OSAS patients.
Study design:
BASELINE: 1. NASAL SYMPTOMS 2. NASAL RESISTANCE 3. NASAL WASH (IL-6, IL-8, TNF-a, IL-10)
3 weeks humidified CPAP --------------> 3 weeks non-humidified CPAP <--------------
AFTER TREATMENT: 1. NASAL SYMPTOMS 2. NASAL RESISTANCE 3. NASAL WASH (IL-6, IL-8, TNF-a, IL-10)
Methods:
- Nasal symptoms will be assessed using a five point Nasal Score. Each of the five principal nasal symptoms of rhinorrhoea, post-nasal drip, sneezing, impaired sense of smell and nasal blockage will be binary coded as present/increased over baseline (1) or absent/not (0) and summed to yield a total Nasal Score between zero and five.
- Nasal resistance will be assessed by active anterior and posterior rhinomanometry in both seated and supine (for 10 min) positions.
- Nasal wash will be performed using a technique adapted by Hurst et al. Briefly, a 12-French Foley catheter (Bard, Crawley, UK), modified by removal of the tip distal to the balloon, was inserted into the nostril and inflated with sufficient air to form a comfortable seal (typically 7-10ml). With the patients head flexed 45o forward, 7ml of warmed 0.9% saline will be instilled through the catheter and washed in and out of the nasal cavity three times. A portion of the pooled wash from both nostrils will be centrifuged to yield a supernatant for analysis of inflammatory cytokines.
By this protocol, the following are expected: a) the reason for potential congestion and inflammatory response is cold and dry air passing through the nostrils (mechanical irritation cannot be the reason, as the pressure is equivalent in both sessions), and b) heated and humidified CPAP prevents (and not treats) nasal congestion.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
-
Athens, Hellas, 10675
- Department of Critical Care and Pulmonary Services, Evangelismos Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Obstructive sleep apnea syndrome defined as apnea/hypopnoea index greater than 20,
- Initiation of continuous positive airway pressure, and
- Symptomatic nasal obstruction.
Exclusion Criteria:
- No medication known to influence nasal resistance (antihistamines, vasoconstrictors, vasodilators, topical or systemic steroids, and recreation drugs),
- No smoking,
- No upper or lower respiratory tract disease (e.g. upper respiratory tract infection, rhinitis, sinusitis, chronic obstructive pulmonary disease), including a history of nasal allergy.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Ioannis Koutsourelakis, MD, 1Center of Sleep Disorders Medical School of Athens University, Department of Critical Care and Pulmonary Services
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Kushida CA, Chediak A, Berry RB, Brown LK, Gozal D, Iber C, Parthasarathy S, Quan SF, Rowley JA; Positive Airway Pressure Titration Task Force; American Academy of Sleep Medicine. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med. 2008 Apr 15;4(2):157-71.
- Willing S, San Pedro M, Driver HS, Munt P, Fitzpatrick MF. The acute impact of continuous positive airway pressure on nasal resistance: a randomized controlled comparison. J Appl Physiol (1985). 2007 Mar;102(3):1214-9. doi: 10.1152/japplphysiol.00639.2006. Epub 2006 Dec 7.
- Randerath WJ, Meier J, Genger H, Domanski U, Ruhle KH. Efficiency of cold passover and heated humidification under continuous positive airway pressure. Eur Respir J. 2002 Jul;20(1):183-6. doi: 10.1183/09031936.02.00267902.
- Mador MJ, Krauza M, Pervez A, Pierce D, Braun M. Effect of heated humidification on compliance and quality of life in patients with sleep apnea using nasal continuous positive airway pressure. Chest. 2005 Oct;128(4):2151-8. doi: 10.1378/chest.128.4.2151.
- Bossi R, Piatti G, Roma E, Ambrosetti U. Effects of long-term nasal continuous positive airway pressure therapy on morphology, function, and mucociliary clearance of nasal epithelium in patients with obstructive sleep apnea syndrome. Laryngoscope. 2004 Aug;114(8):1431-4. doi: 10.1097/00005537-200408000-00022.
- Hurst JR, Perera WR, Wilkinson TM, Donaldson GC, Wedzicha JA. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006 Jan 1;173(1):71-8. doi: 10.1164/rccm.200505-704OC. Epub 2005 Sep 22.
- Richards GN, Cistulli PA, Ungar RG, Berthon-Jones M, Sullivan CE. Mouth leak with nasal continuous positive airway pressure increases nasal airway resistance. Am J Respir Crit Care Med. 1996 Jul;154(1):182-6. doi: 10.1164/ajrccm.154.1.8680678.
- Togias AG, Naclerio RM, Proud D, Fish JE, Adkinson NF Jr, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest. 1985 Oct;76(4):1375-81. doi: 10.1172/JCI112113.
- Almendros I, Acerbi I, Vilaseca I, Montserrat JM, Navajas D, Farre R. Continuous positive airway pressure (CPAP) induces early nasal inflammation. Sleep. 2008 Jan;31(1):127-31. doi: 10.1093/sleep/31.1.127.
- Koutsourelakis I, Vagiakis E, Perraki E, Karatza M, Magkou C, Kopaka M, Roussos C, Zakynthinos S. Nasal inflammation in sleep apnoea patients using CPAP and effect of heated humidification. Eur Respir J. 2011 Mar;37(3):587-94. doi: 10.1183/09031936.00036910. Epub 2010 Jul 1.
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- UOA-12008
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Obstruktivt søvnapnésyndrom
-
Brigham and Women's HospitalAktiv, ikke rekrutterendeSøvnforstyrrelser, iboende | Søvnforstyrrelser, døgnrytme | Advanced Sleep Phase Syndrome (ASPS) | Forsinket søvnfasesyndrom | Skift-arbeid søvnforstyrrelse | Forsinket søvnfase | Ikke-24 timers søvn- og våkneforstyrrelse | Advanced Sleep Phase Syndrome | Avansert søvnfase | Uregelmessig søvn-våkne-syndrom | Skift...Forente stater
-
Brigham and Women's HospitalCharite University, Berlin, Germany; Stanford UniversityRekrutteringSøvnforstyrrelser, iboende | Søvnvåkenforstyrrelser | Søvnforstyrrelser, døgnrytme | Advanced Sleep Phase Syndrome (ASPS) | Forsinket søvnfasesyndrom | Skift-arbeid søvnforstyrrelse | Forsinket søvnfase | Ikke-24 timers søvn- og våkneforstyrrelse | Advanced Sleep Phase Syndrome | Avansert søvnfase | Uregelmessig... og andre forholdForente stater
-
Tyco Healthcare GroupUkjent
-
Maastricht University Medical CenterEpilepsiecentrum KempenhaegheFullførtRolandsk epilepsi | Landau-Kleffners syndrom | Nattlig frontallappepilepsi | Elektrisk status Epilepticus under Slow Wave SleepNederland
-
Brigham and Women's HospitalStanford UniversityRekrutteringSøvnvåkenforstyrrelser | Søvnforstyrrelse | Søvnforstyrrelser, døgnrytme | Døgnrytmeforstyrrelser | Døgnrytme søvnforstyrrelse | Advanced Sleep Phase Syndrome (ASPS) | Forsinket søvnfasesyndromForente stater